Corline Biomedical (Sweden) Today
| CLBIO Stock | SEK 10.25 0.15 1.44% |
Performance0 of 100
| Odds Of DistressOver 66
|
Corline Biomedical is selling for under 10.25 as of the 25th of April 2024; that is -1.44 percent decrease since the beginning of the trading day. The stock's lowest day price was 10.05. Corline Biomedical has more than 66 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Corline Biomedical AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of March 2024 and ending today, the 25th of April 2024. Click here to learn more.
Corline Biomedical AB develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications. The company was founded in 1991 and is based in Uppsala, Sweden. Corline Biomedical operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. The company has 21.49 M outstanding shares. More on Corline Biomedical AB
Moving together with Corline Stock
| 0.95 | GENO | Genovis AB | PairCorr |
| 0.66 | HNSA | Hansa Biopharma AB | PairCorr |
Moving against Corline Stock
| 0.71 | BINV | BioInvent International | PairCorr |
| 0.56 | XSPRAY | XSpray Pharma AB | PairCorr |
| 0.53 | EGTX | Egetis Therapeutics | PairCorr |
Corline Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Corline Biomedical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Corline Biomedical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | Drugs (View all Themes) |
| Business Concentration | Drugs, Biotechnology, Healthcare (View all Sectors) |
Corline Biomedical AB (CLBIO) is traded on Stockholm Exchange in Sweden and employs 10 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 203.87 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Corline Biomedical's market, we take the total number of its shares issued and multiply it by Corline Biomedical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Corline Biomedical operates under Healthcare sector and is part of Biotechnology industry. The entity has 21.49 M outstanding shares.
Corline Biomedical AB has accumulated about 41.63 M in cash with (4.83 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.45.
Check Corline Biomedical Probability Of Bankruptcy
Ownership AllocationCorline Biomedical holds a total of 21.49 Million outstanding shares. Corline Biomedical AB retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Corline Ownership Details
Corline Stock Price Odds Analysis
Attributed to a normal probability distribution, the odds of Corline Biomedical jumping above the current price in 90 days from now is about 98.0%. The Corline Biomedical AB probability density function shows the probability of Corline Biomedical stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Corline Biomedical AB has a beta of -0.3126 suggesting as returns on the benchmark increase, returns on holding Corline Biomedical are expected to decrease at a much lower rate. During a bear market, however, Corline Biomedical AB is likely to outperform the market. Additionally, corline Biomedical AB has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Corline Biomedical to move above the current price in 90 days from now is about 98.0 (This Corline Biomedical AB probability density function shows the probability of Corline Stock to fall within a particular range of prices over 90 days) .
Corline Biomedical Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Corline Biomedical market risk premium is the additional return an investor will receive from holding Corline Biomedical long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Corline Biomedical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Corline Biomedical's alpha and beta are two of the key measurements used to evaluate Corline Biomedical's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.95 | |||
| Standard Deviation | 2.5 | |||
| Variance | 6.23 | |||
| Risk Adjusted Performance | (0.13) |
Corline Stock Against Markets
Picking the right benchmark for Corline Biomedical stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Corline Biomedical stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Corline Biomedical is critical whether you are bullish or bearish towards Corline Biomedical AB at a given time. Please also check how Corline Biomedical's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Corline Biomedical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Economic Indicators Now
Economic IndicatorsTop statistical indicators that provide insights into how an economy is performing |
| All Next | Launch Module |
How to buy Corline Stock?
Before investing in Corline Biomedical, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Corline Biomedical. To buy Corline Biomedical stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Corline Biomedical. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Corline Biomedical stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Corline Biomedical AB stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Corline Biomedical AB stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Corline Biomedical AB, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Corline Biomedical AB?
The danger of trading Corline Biomedical AB is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Corline Biomedical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Corline Biomedical. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Corline Biomedical is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Corline Biomedical AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Complementary Tools for Corline Stock analysis
When running Corline Biomedical's price analysis, check to measure Corline Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corline Biomedical is operating at the current time. Most of Corline Biomedical's value examination focuses on studying past and present price action to predict the probability of Corline Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corline Biomedical's price. Additionally, you may evaluate how the addition of Corline Biomedical to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |